Indivior Shares Outstanding 2012-2020 | INVVY

Indivior shares outstanding from 2012 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Indivior Annual Shares Outstanding
(Millions of Shares)
2019 151
2018 150
2017 144
2016 149
2015 147
2014 145
2013 145
2012
2011
Indivior Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 200
2020-06-30 180
2020-03-31 155
2019-12-31 151
2019-09-30 160
2019-06-30 150
2019-03-31 151
2018-12-31 150
2018-09-30 150
2018-06-30 150
2018-03-31 150
2017-12-31 144
2017-09-30 150
2017-06-30 150
2017-03-31 150
2016-12-31 149
2016-09-30 149
2016-06-30 149
2016-03-31 146
2015-12-31 147
2015-09-30 147
2015-06-30 147
2015-03-31 145
2014-12-31
2014-09-30 145
2014-06-30 145
2013-12-31
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.246B $0.785B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.952B 38.78
Takeda Pharmaceutical (TAK) Japan $55.835B 10.24
Astellas Pharma (ALPMY) Japan $30.161B 18.62
Eisai (ESALY) Japan $20.484B 22.72
Catalent (CTLT) United States $18.447B 48.81
Grifols, S.A (GRFS) Spain $11.001B 12.80
Jazz Pharmaceuticals (JAZZ) Ireland $9.176B 15.32
Neurocrine Biosciences (NBIX) United States $8.926B 20.70
Arrowhead Pharmaceuticals (ARWR) United States $7.834B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
Ionis Pharmaceuticals (IONS) United States $7.440B 0.00
United Therapeutics (UTHR) United States $7.270B 14.12
IPSEN SA ADR (IPSEY) France $7.107B 0.00
Evotec AG (EVTCY) Germany $6.260B 422.78
Orion OYJ (ORINY) Finland $5.794B 20.11
Turning Point Therapeutics (TPTX) United States $5.470B 0.00
Sage Therapeutics (SAGE) United States $4.447B 0.00
Tilray (TLRY) Canada $4.344B 0.00
ChemoCentryx (CCXI) United States $4.341B 0.00
Nektar Therapeutics (NKTR) United States $4.270B 0.00
PTC Therapeutics (PTCT) United States $4.008B 0.00
Cronos Group (CRON) Canada $3.714B 0.00
Hypermarcas (HYPMY) Brazil $3.465B 13.68
FibroGen (FGEN) United States $3.145B 0.00
Revolution Medicines (RVMD) United States $3.063B 0.00
Pacira BioSciences (PCRX) United States $3.042B 51.37
Corcept Therapeutics (CORT) United States $2.864B 28.72
Taro Pharmaceutical Industries (TARO) Israel $2.735B 16.94
Xencor (XNCR) United States $2.593B 0.00
AlloVir (ALVR) United States $2.416B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.107B 0.00
USANA Health Sciences (USNA) United States $2.094B 17.14
Sundial Growers (SNDL) Canada $2.030B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.831B 0.00
ImmunoGen (IMGN) United States $1.736B 0.00
Organogenesis Holdings (ORGO) United States $1.662B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.605B 12.62
Translate Bio (TBIO) United States $1.594B 0.00
Heron Therapeutics (HRTX) United States $1.579B 0.00
Endo (ENDP) Ireland $1.579B 2.39
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.466B 9.40
Ocular Therapeutix (OCUL) United States $1.333B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.217B 0.00
Zogenix (ZGNX) United States $1.148B 0.00
Aclaris Therapeutics (ACRS) United States $1.139B 0.00
Trillium Therapeutics (TRIL) Canada $1.081B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.004B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Karyopharm Therapeutics (KPTI) United States $0.921B 0.00
Aerie Pharmaceuticals (AERI) United States $0.918B 0.00
Radius Health (RDUS) United States $0.900B 0.00
Esperion Therapeutics (ESPR) United States $0.768B 0.00
Collegium Pharmaceutical (COLL) United States $0.760B 28.78
VAXART, INC (VXRT) United States $0.749B 0.00
Chinook Therapeutics (KDNY) United States $0.731B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.722B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.651B 0.00
Ardelyx (ARDX) United States $0.619B 0.00
KalVista Pharmaceuticals (KALV) United States $0.578B 0.00
Flexion Therapeutics (FLXN) United States $0.556B 0.00
Jounce Therapeutics (JNCE) United States $0.555B 0.00
Molecular Templates (MTEM) United States $0.542B 0.00
Acutus Medical (AFIB) United States $0.540B 0.00
Altimmune (ALT) United States $0.534B 0.00
Rafael Holdings (RFL) United States $0.527B 0.00
Akebia Therapeutics (AKBA) United States $0.517B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.512B 0.00
AVITA Medical (RCEL) United States $0.507B 0.00
Harpoon Therapeutics (HARP) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.506B 14.22
Summit Therapeutics (SMMT) United States $0.492B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.479B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.450B 0.00
PROFOUND MEDICL (PROF) Canada $0.441B 0.00
DURECT (DRRX) United States $0.439B 0.00
TherapeuticsMD (TXMD) United States $0.438B 0.00
MEI Pharma (MEIP) United States $0.412B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.381B 9.95
VYNE Therapeutics (VYNE) United States $0.380B 0.00
Innate Pharma SA (IPHYF) France $0.356B 0.00
Nature's Sunshine Products (NATR) United States $0.343B 22.09
Redhill Biopharma (RDHL) Israel $0.323B 0.00
Alpine Immune Sciences (ALPN) United States $0.315B 0.00
CASI Pharmaceuticals (CASI) United States $0.296B 0.00
KemPharm (KMPH) United States $0.254B 0.00
Xeris Pharmaceuticals (XERS) United States $0.253B 0.00
Lannett Co Inc (LCI) United States $0.252B 8.44
CTI BioPharma (CTIC) United States $0.245B 0.00
Onconova Therapeutics (ONTX) United States $0.238B 0.00
Novan (NOVN) United States $0.237B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.235B 0.00
Oncternal Therapeutics (ONCT) United States $0.231B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Jaguar Animal Health (JAGX) United States $0.222B 0.00
Concert Pharmaceuticals (CNCE) United States $0.216B 0.00
OptiNose (OPTN) United States $0.198B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.198B 0.00
Calithera Biosciences (CALA) United States $0.198B 0.00
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
Nutriband (NTRB) United States $0.197B 0.00
Heat Biologics (HTBX) United States $0.196B 0.00
Iterum Therapeutics (ITRM) Ireland $0.194B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.187B 0.00
Qilian Holding Group (QLI) China $0.186B 0.00
Infinity Pharmaceuticals (INFI) United States $0.186B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.171B 0.00
IsoRay (ISR) United States $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.170B 0.00
Aquestive Therapeutics (AQST) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.158B 0.00
Genocea Biosciences (GNCA) United States $0.155B 0.00
Aziyo Biologics (AZYO) United States $0.153B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
MediWound (MDWD) Israel $0.151B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.136B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Assertio Holdings (ASRT) United States $0.127B 0.00
Otonomy (OTIC) United States $0.125B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.124B 0.00
Lipocine (LPCN) United States $0.117B 0.00
ProPhase Labs (PRPH) United States $0.106B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
ElectroCore (ECOR) United States $0.102B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.096B 0.00
SCYNEXIS (SCYX) United States $0.095B 0.00
Natural Alternatives (NAII) United States $0.093B 25.19
AIM ImmunoTech (AIM) United States $0.092B 0.00
Recro Pharma (REPH) United States $0.092B 0.00
Baudax Bio (BXRX) United States $0.091B 0.00
AgeX Therapeutics (AGE) United States $0.089B 0.00
PolarityTE (PTE) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
Brickell Biotech (BBI) United States $0.079B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.074B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.074B 0.00
Addex Therapeutics (ADXN) Switzerland $0.073B 0.00
Sigyn Therapeutics (SIGY) United States $0.071B 0.00
CV Sciences (CVSI) United States $0.070B 0.00
Biomerica (BMRA) United States $0.070B 0.00
Inhibikase Therapeutics (IKT) United States $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.15
Plus Therapeutics (PSTV) United States $0.051B 0.00
Regulus Therapeutics (RGLS) United States $0.050B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.043B 0.00
RXi Pharmaceuticals (PHIO) United States $0.041B 0.00
Neos Therapeutics (NEOS) United States $0.040B 0.00
Mannatech (MTEX) United States $0.039B 5.70
Salarius Pharmaceuticals (SLRX) United States $0.038B 0.00
Can-Fite Biopharma (CANF) Israel $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Cyanotech (CYAN) United States $0.023B 18.80
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
JanOne (JAN) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
SHINECO INC (TYHT) China $0.013B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00